Preclinical pharmacology of milnacipran

International Clinical Psychopharmacology

Volumn 11, Issue SUPPL. 4, 1996, Pages 9-14

  Briley, M ^a   Prost, J F ^a   Moret, C ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Antidepressant; Noradrenaline uptake; Serotonin uptake

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; HISTAMINE RECEPTOR; MILNACIPRAN; MUSCARINIC RECEPTOR; NORADRENALIN; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; BIOAVAILABILITY; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROTRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029833364     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199609004-00002     Document Type: Conference Paper

References (22)

1. Assié MB, Le Lann AD, Stenger A, Briley M (1990) Repeated administration of milnacipran, a new antidepressant, has no effect on a functional beta-adrenergic response in the rat brain. Eur J Pharmacol 183:741-742.
2. Assié MB, Charvéron M, Palmier C, Puozzo C, Moret C, Briley M (1992) Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat. Neuropharmacology 31:149-155.
3. 3H]milnacipran, a new antidepressant drug, and their relationship to the serotonin transporter in rat brain. Brain Research 668:129-143.
4. Blier P, Weiss M, De Montigny C (1992) Effects of sustained administration of milnacipran on serotonin and noradrenaline neurotransmissions in rat hippocampus [abstract]. In Symposium on The Role of Serotonin in Psychiatric Disorders, Castres: 9. Castres: Pierre Fabre Research Centre.
5. Carré JB, Boutry JM, Baumann N, Maurin Y (1988) Acidic sphingomyelinase: relationship with antidepressant-induced desensitization of beta-adrenoceptors. Life Sci 42:769-774.
6. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 90:131-138.
7. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affective Disorders 18:289-299.
8. Göthert M, Huth H, Schlicker E (1981) Characterization of the receptor subtype involved in alpha adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol 317:199-203.
9. Lacroix P, Rocher N Gandon JM, Panconi E (1995) Antidepressant effects of milnacipran in the learned helplessness test in rats [abstract]. In Abstract book, ECNP meeting, Venice. Utrecht: European College of Neuropsychopharmacology.
10. Matsubara R, Koyama T, Odagaki Y, Nakayama M, Inoue T, Yamashita I (1988) Pharmacological properties of Midalcipran (F 2207), a novel antidepressant [abstract]. Psychopharmacology 96 (suppl 3):273.
11. Matsubara R, Koyama T, Muraki A, et al. (1990) Effect of chronic treatment with milnacipran (F 2207) on β-adrenergic receptor-adenylate cyclase system in rat cerebral cortex [abstract]. In Abstract book, 17th CINP meeting, Kyoto, p 70. Copenhagen: Collegium Internationale Neuro-Psychopharmacologicum, University of Copenhagen.
12. Moret C, Briley M (1990) Serotonin autoreceptor subsensitivity and antidepressant activity. Eur J Pharmacol 180:351-356.
13. Moret C, Briley M (1992) Effect of antidepressant drugs on monoamine synthesis in brain in vivo. Neuropharmacology 31:679-684.
14. Moret C, Briley M (1994) Effect of milnacipran and desipramine on noradrenergic alpha 2-autoreceptor sensitivity. Prog Neuropsychopharmacol Biol Psychiatry 18:1063-1072.
15. Moret C, Briley M (1996) In vivo study of monoamines neurotransmission by milnacipran, a double noradrenaline and serotonin reuptake inhibiting antidepressant [abstract]. Brain Research Association Abstracts 13:35.
16. Moret C, Charvéron M, Finberg JPM, Couzinier JP, Briley M (1985) Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology 24:1211-1219.
17. Neliat G, Bodinier M-C, Panconi E, Briley M (1996) Lack of effect of repeated administration of milnacipran, a double noradrenaline and serotonin reuptake inhibitor, on the α-adrenoceptor-linked adenylate cyclase system in the rat cerebral cortex. Neuropharmacology (in press).
18. Redmond AM, Kelly JP, Leonard BE (1995) The behavioural effects of milnacipran in the olfactory bulbectomised rat model of depression. Med Sci Res 23:533-534.
19. Richelson E (1994) Pharmacology of antidepressants: characteristics of the ideal drug. Mayo Clinic Proc 69:1069-1081.
20. Stenger A, Couzinier JP, Briley M (1987) Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane hydrochloride (F 2207), a new potential antidepressant. Psychopharmacology 91:147-153.
21. Van Praag HM (1983) In search of the mode of action of antidepressants: 5-HTP/tyrosine mixtures in depressions. Neuropharmacology 22:433-440.
22. Van Praag HM (1984) Studies in the mechanism of action of serotonin precursors in depression. Psychopharmacol Bull 20:599-602.